AI Summary
Description
General Information Document Type: Presolicitation Synopsis Number: 75N98027Q00086 Posted Date: November 16, 2026 Original Response Date: November 26, 2026 Current Response Date: November 26, 2026 Set Aside: N/A NAICS Code: 541380 Contracting Office Address National Institutes of Health (NIH), Office of the Director (OD) Office of Logistics and Operations (OLAO) Office of Acquisition and Logistics Management (OALM) Hospital and Laboratory Support Division 6701 Rockledge Drive Bethesda, MD 20817 Description INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: Eminent Services Corp 7495 New Technology WAY Frederick, Maryland 21703 NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541380 with a Size Standard $19,000,000. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION Title: Storage and monitoring of ManNac for FDA regulations Background Information: Under this task order, the contractor will independently provide support services to satisfy the overall operational objectives of the National Human Genome Research Institute (NHGRI). The refrigerated storage of the clinical grade drug-in-sachet needs to be conducted under strict temperature control and FDA-regulatory requirements. NHGRI wants to contract a company for long-term refrigerated storage of a large batch of our unlabeled investigational drug N-acetylmannosamine (ManNAc), the drug is packaged as powder-in-sachets and stored in 16 boxes (8x12x14''box dimensions) and contain 600 sachets/box. NHGRI plans to use this drug in future clinical trials of ManNAc for other indications, such as GNE-related thrombocytopenia or nephrotic disease. NHGRI anticipates storing this batch of unlabeled drug at a company for a period of up to 2 years. The refrigerated storage of the clinical grade drug-in-sachet needs to be conducted under strict temperature control and FDA-regulatory requirements. …
Classification
Place of Performance
Contracting Office
Contacts